Impact of granulocyte colony-stimulating factor use during induction for acute myelogenous leukemia in children: A report from the Children's Cancer Group Article Conference Paper uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Piperazines
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Pyrimidines

abstract

  • The incidence of severe toxic event and infection, induction remission rate, overall survival, and event-free survival were comparable regardless of G-CSF use. Use of G-CSF decreased neutropenia duration, hospital stay, and length of induction. Patients with hypercellular day 7 bone marrow who received G-CSF had an induction remission rate and event-free survival superior to those of patients who did not receive G-CSF.

publication date

  • November 2002

Research

keywords

  • Conference Paper

Identity

Digital Object Identifier (DOI)

  • 10.1097/00043426-200211000-00006

PubMed ID

  • 12439034

Additional Document Info

start page

  • 627

end page

  • 35

volume

  • 24

number

  • 8